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The cover shows immunohistochemical sections of xenografts derived from gemcitabine-sensitive CAL29 bladder cancer cells. Sections were stained for Dck, and nuclear positivity was quantified using Aperio scanscope software, using the Nuclear v9 algorithm. For details, see the article by Kerr and colleagues on page 5435 of this issue.
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